Research.Patient.info
metastatic non-small cell lung cancer (NSCLC) research hub
4 indexed studies · 0 currently recruiting
- authorisedPhase I and Phase II (Integrated)- Other
A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cell Lung Cancer (ALTAIR)
This study, called ALTAIR, is looking at new combinations of medicines for advanced or metastatic non-small cell lung cancer. It aims to find a safe and effective dose, and see how well these new treatments work.
Germany · Spain · France - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with Pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of Head and Neck (SCCHN), or Metastatic Urothelial Bladder Cancer (mUBC)
Spain - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Phase IB Study to determine efficacy and safety of Durvalumab and/or novel anti-cancer agents, with or without chemotherapy, in patients with previously untreated NSCLC
Poland - ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Metastatic Non-Small Cell Lung Cancer (Morpheus-Lung)
France · Spain